Xilio Therapeutics Inc (XLO)
1.14
+0.06
(+5.56%)
USD |
NASDAQ |
May 17, 16:00
1.14
0.00 (0.00%)
After-Hours: 20:00
Xilio Therapeutics Market Cap: 42.08M for May 17, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 17, 2024 | 42.08M |
| May 16, 2024 | 39.87M |
| May 15, 2024 | 41.34M |
| May 14, 2024 | 40.23M |
| May 13, 2024 | 41.34M |
| May 10, 2024 | 43.56M |
| May 09, 2024 | 46.51M |
| May 08, 2024 | 44.66M |
| May 07, 2024 | 46.51M |
| May 06, 2024 | 46.14M |
| May 03, 2024 | 43.56M |
| May 02, 2024 | 38.76M |
| May 01, 2024 | 39.87M |
| April 30, 2024 | 38.39M |
| April 29, 2024 | 38.39M |
| April 26, 2024 | 40.23M |
| April 25, 2024 | 37.28M |
| April 24, 2024 | 39.13M |
| April 23, 2024 | 38.76M |
| April 22, 2024 | 40.60M |
| April 19, 2024 | 42.45M |
| April 18, 2024 | 47.25M |
| April 17, 2024 | 45.40M |
| April 16, 2024 | 47.99M |
| April 15, 2024 | 46.51M |
| Date | Value |
|---|---|
| April 12, 2024 | 43.56M |
| April 11, 2024 | 46.88M |
| April 10, 2024 | 44.13M |
| April 09, 2024 | 45.16M |
| April 08, 2024 | 50.68M |
| April 05, 2024 | 41.37M |
| April 04, 2024 | 41.71M |
| April 03, 2024 | 44.82M |
| April 02, 2024 | 51.02M |
| April 01, 2024 | 52.74M |
| March 28, 2024 | 37.23M |
| March 27, 2024 | 17.64M |
| March 26, 2024 | 18.21M |
| March 25, 2024 | 19.33M |
| March 22, 2024 | 19.53M |
| March 21, 2024 | 19.39M |
| March 20, 2024 | 19.08M |
| March 19, 2024 | 18.91M |
| March 18, 2024 | 18.74M |
| March 15, 2024 | 18.91M |
| March 14, 2024 | 17.85M |
| March 13, 2024 | 19.33M |
| March 12, 2024 | 18.51M |
| March 11, 2024 | 20.89M |
| March 08, 2024 | 22.91M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
13.78M
Minimum
Dec 20 2023
688.82M
Maximum
Nov 16 2021
120.38M
Average
76.44M
Median
Market Cap Benchmarks
| Gilead Sciences Inc | 84.37B |
| FibroGen Inc | 119.37M |
| Avalo Therapeutics Inc | 9.917M |
| IGM Biosciences Inc | 544.20M |
| AEON Biopharma Inc | 32.78M |
Market Cap Related Metrics
| Price to Book Value | 1.633 |
| Price | 1.14 |
| Earnings Yield | -225.4% |